Obstrucción intestinal maligna. Revisión de tema

Soriano A, Davis MP. Malignant bowel obstruction: Individualized treatment for patients near the end of life. Cleve Clin J Med. 2011;78:197-206.

https://doi.org/10.3949/ccjm.78a.10052

Mercadante S, Ferrera P, Villari P, Marrazzo A. Aggressive Pharmacological Treatment for Reversing Malignant Bowel Obstruction. J Pain Symptom Manage. 2004;28:412-6.

https://doi.org/10.1016/j.jpainsymman.2004.01.007

DeBernardo R. Surgical Management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Curr Oncol Rep. 2009;11:287-92.

https://doi.org/10.1007/s11912-009-0040-4

Tuca A, Guell E, Martínez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Res. 2012;4:159-69.

https://doi.org/10.2147/CMAR.S29297

Anthony T, Barón T, Mercadante S, Green S, Chi D, Cunningham J, et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage. 2007; 34(Suppl 1):S49-S59.

https://doi.org/10.1016/j.jpainsymman.2007.04.011

Tuca A, Martínez E, Güell E, Gómez Baptiste X. Malignant bowel obstruction. Med Clin (Barc). 2010;135:375-81.

https://doi.org/10.1016/j.medcli.2010.03.002

Ripamonti C, Mercadante S. Pathophysiology and management of malignant bowel obstruction. En: Doyle D, Hanks G, Cherny N, Keneth C, editores. Oxford textbook of Palliative Medicine. 4.a ed. Oxford: Oxford University Press; 2010.

https://doi.org/10.1093/med/9780198570295.003.0069

Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: A qualitative systematic review. J Pain Symptom Manage. 2009;38:466-72.

Ripamonti C, Easson A, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105-15.

https://doi.org/10.1016/j.ejca.2008.02.028

Alesi E, Bobb B, Smith TJ. How we do it: Guiding patients facing decisions about "futile" chemotherapy. J Support Oncol. 2011; 9:184-7.

https://doi.org/10.1016/j.suponc.2011.04.001

Roeland E, Von Gunten Ch. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009;11:298-303.

https://doi.org/10.1007/s11912-009-0042-2

Krouse RS. Invasive treatment options for malignant bowel obstruction #119. J Palliat Med. 2009;12:1152-3.

https://doi.org/10.1089/jpm.2009.9922

Baron T. Interventional palliative strategies for malignant bowel obstruction. Curr Oncol Rep. 2009;11:293-7.

https://doi.org/10.1007/s11912-009-0041-3

Shaw C, Basset RL, Fox PS, Schmeler KM, Overman MJ, Wallace MJ, et al. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol. 2013;20;497-505.

https://doi.org/10.1245/s10434-012-2643-5

Zhang Y, Shi J, Shi B, Song CY, Xie WF, Chen YX. Comparison of efficacy between uncovered and covered self expanding metallic stents in malignant large bowel obstruction: A systematic review and Meta-analysis. Colorectal Dis. 2012;14:367-74.

https://doi.org/10.1111/j.1463-1318.2012.03056.x

Jeurnink SM, Van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007;7:18.

https://doi.org/10.1186/1471-230X-7-18

Englert ZP, White MA, Fitzgerald TL, Vadlamundi A, Zervoudakis G, Zervos EE. Surgical management of malignant bowel obstruction: at what price palliation. Am Surg. 2012;78:647-52.

Courtney ED, Raja A, Leicester RJ. Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum. 2005;48:845-50.

https://doi.org/10.1007/s10350-004-0833-3

Sherwood LA, Knowles G, Wilson RG, Potter MA. Retrospective review of laser therapy for palliation of colorectal tumours. Eur J Oncol Nurs. 2006;10:30-8.

https://doi.org/10.1016/j.ejon.2005.03.009

Von Gunten Ch, Muir JC. Medical management of bowel obstructions. J Palliat Med. 2009;12:1151-2.

https://doi.org/10.1089/jpm.2009.9923

Mercadante S, Porzio G. Octreotide for malignant bowel obstruction: Twenty years after. Crit Rev Oncol Hematol. 2012; 83:388-92.

https://doi.org/10.1016/j.critrevonc.2011.12.006

Laval G, Rosselot H, Toussain Martel S, Mayer F, Terrebonne E, François E, et al. SALTO: a randomized multicenter study assessing octreotide LAR in inoperable obstruction. Bull Cancer. 2012;99:E1-9.

https://doi.org/10.1684/bdc.2011.1535

Mariani B, Blumberg J, Landau A, Lebrun-Jenekova D, Botton E, Beatrix O, et al. Symptomatic treatment with Lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis. A randomized double-blind placebo controlled phase III study. J Clin Oncol. 2012;30;4337-43.

https://doi.org/10.1200/JCO.2011.40.5712

Kucukmetin A, Naik R, Galaal K, Bryant A, Dickinson HO. Palliative surgery versus medical management for bowel obstruction in ovarian cancer (Review) Cochrane Database Syst Rev. 2010:CD007792.

https://doi.org/10.1002/14651858.CD007792.pub2

Watari H, Hosaka M, Wakui Y, Nomura E, Hareyama H, Tanuma F, et al. A prospective study on the efficacy of octreotide in the management of malignant bowel obstruction in gynecologic cancer. Int J Gynecol Cancer. 2012;22:692-6.

https://doi.org/10.1097/IGC.0b013e318244ce93

Hinasaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, et al. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol. 2010;40:739-45.

https://doi.org/10.1093/jjco/hyq048

Feuer DJ, Broadley KE. Corticosteroides para la resolución de la obstrucción intestinal maligna en el cáncer avanzado ginecológico y gastrointestinal. Cochrane Database Syst Rev [internet]. 2008 [consultado 26 Ene 2013]. Disponible en: http://www.update-software.com

Levy MH, Adolph MD, Block S, Codada SN. Palliative Care. Symptoms: Malignant Bowel Obstruction. NCCN Clinical Practice Guidelines in Oncology Version 2 [internet]. 2012 [consultado 26 Ene 2013]. Disponible en: http://www.NCCN.org

Porzio G, Aielli F, Verna L, Galleti B, Shoja E, Razavi G, et al. Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer. 2011;19:431-33.

https://doi.org/10.1007/s00520-010-1009-4

Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R, et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction. Do the benefits outweigh the risks? Med Oncol. 2011;28:83-8.

https://doi.org/10.1007/s12032-010-9426-2

Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S, et al. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition. 2004;20:760-3.

https://doi.org/10.1016/j.nut.2004.05.010

Orrevall Y, Tishelman C, Permert J. Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr. 2005;24:961-70.

https://doi.org/10.1016/j.clnu.2005.06.008

Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28:445-54.

https://doi.org/10.1016/j.clnu.2009.04.011

Withworth MK, Withfield A, Serena H, Shaffer J, Makin W, Jayson GC. Doctor, does this mean I ́m going to starve to death? JCO. 2004;22:199-201.

https://doi.org/10.1200/JCO.2004.02.056

Ng WC, Fung YLJ, Siu Man S, Ying Chang R. Short term and long-term outcomes of patients with malignant large bowel obstruction. Surg Pract. 2006;10:57-61.

https://doi.org/10.1111/j.1744-1633.2006.00293.x

Henry JC, Pouly S, Sullivan R, Sharif S, Klemanski D, Abdel-Misih S, et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012;152:747-57.

https://doi.org/10.1016/j.surg.2012.07.009